Chronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature Review
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project.
Hepatic Metabolic Dysregulation as a Potential Amplifier of Leukemogenesis Following mRNA Vaccination: A Novel Mechanistic Hypothesis.
Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration.
Periorbital edema and phototoxic rash associated with dasatinib: A case report.
Comparison of regimens targeting complete remission in the first-line treatment of acute myeloid leukemia patients.
Coexistence of HHV-8-Associated Plasmacytic Multicentric Castleman Disease, Kaposi's Sarcoma, and Multiple Myeloma in a HIV-Negative Patient.
Lipotoxicity-Related Hematological Disorders in Obesity.
Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome.
Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells.
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study
Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.
Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.
The probiotic-induced disregulation of immune-related genes in colon cells and relation with colorectal cancer
Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center.
Hypophosphatemia related to the use of ibrutinib.
A single-center experience of haploidentical stem cell transplantation in hematological malignancies.
Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874
NK-cell dysfunction of acute myeloid leukemia in relation to the renin-angiotensin system and neurotransmitter genes.
Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Determination of etiology in patients admitted due to isolated leukopenia.
Antineoplastic Effects of Ankaferd Hemostat.
Hematological aspects of the COVID-19 syndrome.
Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study.
Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.
Current community transmission and future perspectives on the COVID-19 process
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients.
A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura.
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Three critical clinicobiological phases of the human SARS-associated coronavirus infections.
A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus.
Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis.
Mantle cell lymphoma: a Turkish Multi-Center Study.
Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study.
The Factors Affecting Early Death in Newly Diagnosed APL Patients.
The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia.
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.
Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma.
Indications and Outcomes of Splenectomy for Hematological Disorders.
The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia.
Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia.
Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia.
Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors.
Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case
Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients.
Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors.
Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Lipotoxicity-Related Hematological Disorders in Obesity.
Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines.
Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis.
Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level.
Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission.
Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies.
Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma.
The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice.
Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case.
Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.
The factors affecting early death after the initial therapy of acute myeloid leukemia.
Clinicopathological associations of acquired erythroblastopenia.
Chimeric antigen receptor T cell treatment in hematologic malignancies.
Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib
Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease.
A T-cell prolymphocytic leukemia case with central nervous system involvement.
Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report.
Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.
Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse.
Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case.
Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib.
Rebound Thrombocytosis following Induction Chemotherapy is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission.